306 related articles for article (PubMed ID: 20963563)
1. Discrimination of prolactinoma from hyperprolactinemic non-functioning adenoma.
Hong JW; Lee MK; Kim SH; Lee EJ
Endocrine; 2010 Feb; 37(1):140-7. PubMed ID: 20963563
[TBL] [Abstract][Full Text] [Related]
2. [Hyperprolactinemia in patients with non-functioning adenoma: analysis of 85 patients treated by transsphenoidal operation].
Saitoh Y; Mori S; Arita N; Hayakawa T; Mogami H; Oku Y; Onishi T; Uozumi T
No Shinkei Geka; 1987 Nov; 15(11):1175-9. PubMed ID: 3437926
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic evaluation of hyperprolactinemia.
Biller BM
J Reprod Med; 1999 Dec; 44(12 Suppl):1095-9. PubMed ID: 10649817
[TBL] [Abstract][Full Text] [Related]
4. Clinical practice. Prolactinoma.
Schlechte JA
N Engl J Med; 2003 Nov; 349(21):2035-41. PubMed ID: 14627789
[No Abstract] [Full Text] [Related]
5. Galactorrhea may be clue to serious problems. Patients deserve a thorough workup.
Whitman-Elia GF; Windham NQ
Postgrad Med; 2000 Jun; 107(7):165-8, 171. PubMed ID: 10887453
[TBL] [Abstract][Full Text] [Related]
6. Lack of tumor reduction in hyperprolactinemic women with extrasellar macroadenomas treated with bromocriptine.
Boulanger CM; Mashchak CA; Chang RJ
Fertil Steril; 1985 Oct; 44(4):532-5. PubMed ID: 4054327
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of transsphenoidal surgery in prolactinomas: improvement of hormonal control in dopamine agonist-resistant patients.
Primeau V; Raftopoulos C; Maiter D
Eur J Endocrinol; 2012 May; 166(5):779-86. PubMed ID: 22301915
[TBL] [Abstract][Full Text] [Related]
8. [Current diagnosis and treatment of hyperprolactinemia].
Melgar V; Espinosa E; Sosa E; Rangel MJ; Cuenca D; Ramírez C; Mercado M
Rev Med Inst Mex Seguro Soc; 2016; 54(1):111-21. PubMed ID: 26820213
[TBL] [Abstract][Full Text] [Related]
9. [Macroadenoma of the pituitary gland with moderate hyperprolactinaemia].
Harms E; Siggelkow H; Buchfelder M; Saeger W; Hüfner M
Dtsch Med Wochenschr; 2003 Mar; 128(13):667-70. PubMed ID: 12660899
[TBL] [Abstract][Full Text] [Related]
10. The characteristics of acromegalic patients with hyperprolactinemia and the differences with hyperprolactinemia patients.
Huan C; Cui G; Ren Z
Pak J Pharm Sci; 2015 Mar; 28(2 Suppl):713-8. PubMed ID: 25796163
[TBL] [Abstract][Full Text] [Related]
11. Serum prolactin concentration at presentation of non-functioning pituitary macroadenomas.
Behan LA; O'Sullivan EP; Glynn N; Woods C; Crowley RK; Tun TK; Smith D; Thompson CJ; Agha A
J Endocrinol Invest; 2013; 36(7):508-14. PubMed ID: 23385474
[TBL] [Abstract][Full Text] [Related]
12. Two-step development of a pituitary adenoma: from hyperprolactinemic syndrome to Cushing's disease.
Gheri RG; Boddi W; Ammannati F; Olivotto J; Nozzoli C; Franchi A; Bordi L; Luisi ML; Mennonna P
J Endocrinol Invest; 1997 Apr; 20(4):240-4. PubMed ID: 9211134
[TBL] [Abstract][Full Text] [Related]
13. Nonfunctioning pituitary macroadenoma presenting with mild hyperprolactinemia and amenorrhea.
Hansen KA; Tho SP; Gomez F; McDonough PG
Fertil Steril; 1999 Oct; 72(4):663-5. PubMed ID: 10521106
[TBL] [Abstract][Full Text] [Related]
14. Ropinirole for the Treatment of Hyperprolactinemia: A Dose-Escalation Study of Efficacy and Tolerability.
Heneghan LJ; Tsang A; Dimino C; Khandji AG; Panigrahi SK; Page-Wilson G
J Clin Endocrinol Metab; 2024 Jan; 109(2):e667-e674. PubMed ID: 37715962
[TBL] [Abstract][Full Text] [Related]
15. Predictors of the Response to Dopaminergic Therapy in Patients With Prolactinoma.
Hage C; Salvatori R
J Clin Endocrinol Metab; 2020 Dec; 105(12):. PubMed ID: 32930718
[TBL] [Abstract][Full Text] [Related]
16. Surgical outcomes in hyporesponsive prolactinomas: analysis of patients with resistance or intolerance to dopamine agonists.
Hamilton DK; Vance ML; Boulos PT; Laws ER
Pituitary; 2005; 8(1):53-60. PubMed ID: 16411069
[TBL] [Abstract][Full Text] [Related]
17. Clinical and laboratory features greatly overlap in patients with macroprolactinemia or monomeric hyperprolactinemia.
Vilar L; Naves LA; Freitas MC; Lima M; Canadas V; Albuquerque JL; Lyra R; Azevedo MF; Casulari LA
Minerva Endocrinol; 2007 Jun; 32(2):79-86. PubMed ID: 17557033
[TBL] [Abstract][Full Text] [Related]
18. [The best approach to treat prolactinoma].
Zárate A; Saucedo R; Basurto L
Gac Med Mex; 2004; 140(5):567-9. PubMed ID: 15559242
[TBL] [Abstract][Full Text] [Related]
19. Clinical course of hyperprolactinemia in children and adolescents: a review of 21 cases.
Eren E; Yapıcı Ş; Çakır ED; Ceylan LA; Sağlam H; Tarım Ö
J Clin Res Pediatr Endocrinol; 2011; 3(2):65-9. PubMed ID: 21750634
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis and treatment of pituitary adenomas.
Chanson P; Salenave S
Minerva Endocrinol; 2004 Dec; 29(4):241-75. PubMed ID: 15765032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
